Literature DB >> 33942575

Towards Telemedicine Adoption in Korea: 10 Practical Recommendations for Physicians.

Hun Sung Kim1,2.   

Abstract

Due to the coronavirus disease 2019 (COVID-19) outbreak, consultation and prescription via telemedicine were temporarily allowed in the Korean population. However, at this point, it is difficult to determine whether telemedicine fulfills its role as a health care strategy. Arguably, if we had enough previous experience with telemedicine or sufficient preparation for its application, telemedicine could be more smoothly and flexibly adopted in the medical field. As it is still not possible to predict when the COVID-19 pandemic will end, phone consultation and prescription are likely to continue for some time. Hence, it is expected that telemedicine will naturally settle in the medical field in the near future. However, as we have noticed during this outbreak, improvised telemedicine without adequate guidance can be confusing to both patients and health professionals, thus reducing the benefit to patients. Medical staff requires preparation on how to appropriately use telemedicine. Thus, here we present some suggestions on implementing and preparing for telemedicine in the medical community.
© 2021 The Korean Academy of Medical Sciences.

Entities:  

Keywords:  COVID-19; Delivery of Health Care; Information Science; Telecommunications; Telemedicine

Year:  2021        PMID: 33942575     DOI: 10.3346/jkms.2021.36.e103

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  3 in total

1.  Traditional Korean Medicine Home Care for the Older Adults during the COVID-19 Pandemic in South Korea.

Authors:  Soo-Hyun Sung; You-Sang Baik; Ji-Eun Han; Eun-Jin Lee; Jihye Kim; Minjung Park; Ji-Yeon Lee; Jang-Kyung Park; Jung-Youn Park; Eunkyung Lee
Journal:  Int J Environ Res Public Health       Date:  2022-01-03       Impact factor: 3.390

2.  Normalization of photoplethysmography using deep neural networks for individual and group comparison.

Authors:  Ji Woon Kim; Seong-Wook Choi
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

3.  Survey for Government Policies Regarding Strategies for the Commercialization and Globalization of Digital Therapeutics.

Authors:  Soo Young Kim; Jong Youn Moon; Jaeyong Shin; Jung Yeon Sim; Meelim Kim; Jieun Jang
Journal:  Yonsei Med J       Date:  2022-01       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.